Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shraddha Sapkota

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Alzheimer'S Disease : JAD|February 27, 2018
A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 CarriersShraddha Sapkota, Roger A Dixon
Neurobiology of Aging|January 29, 2017
Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyleShraddha Sapkota, Lars Bäckman, Roger A Dixon
Frontiers in Aging Neuroscience|October 4, 2021
A Multimodal Risk Network Predicts Executive Function Trajectories in Non-demented AgingShraddha Sapkota, G Peggy McFall, Mario Masellis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 8, 2014
Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's diseaseShraddha Sapkota, Myrlene Gee, Jennifer Sabino, et al.
Neurobiology of Aging|August 10, 2014
Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein EShraddha Sapkota, David Vergote, David Westaway, et al.
Neurobiology of Aging|May 5, 2016
Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adultsG Peggy McFall, Shraddha Sapkota, Kirstie L McDermott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2017
Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysisWei Han, Shraddha Sapkota, Richard Camicioli, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 25, 2021
Brain atrophy trajectories predict differential functional performance in Alzheimer's disease: Moderations with apolipoprotein E and sexShraddha Sapkota, Joel Ramirez, Vanessa Yhap, et al.
International Journal of Geriatric Psychiatry|September 8, 2015
Apolipoprotein E and Clusterin can magnify effects of personality vulnerability on declarative memory performance in non-demented older adultsShraddha Sapkota, Sandra A Wiebe, Brent J Small, et al.
Alzheimer'S Research & Therapy|September 7, 2018
Clinical dementia severity associated with ventricular size is differentially moderated by cognitive reserve in men and womenShraddha Sapkota, Joel Ramirez, Donald T Stuss, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Alzheimer'S Disease : JAD|February 27, 2018
A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 CarriersShraddha Sapkota, Roger A Dixon
Neurobiology of Aging|January 29, 2017
Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyleShraddha Sapkota, Lars Bäckman, Roger A Dixon
Frontiers in Aging Neuroscience|October 4, 2021
A Multimodal Risk Network Predicts Executive Function Trajectories in Non-demented AgingShraddha Sapkota, G Peggy McFall, Mario Masellis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 8, 2014
Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's diseaseShraddha Sapkota, Myrlene Gee, Jennifer Sabino, et al.
Neurobiology of Aging|August 10, 2014
Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein EShraddha Sapkota, David Vergote, David Westaway, et al.
Neurobiology of Aging|May 5, 2016
Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adultsG Peggy McFall, Shraddha Sapkota, Kirstie L McDermott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2017
Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysisWei Han, Shraddha Sapkota, Richard Camicioli, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 25, 2021
Brain atrophy trajectories predict differential functional performance in Alzheimer's disease: Moderations with apolipoprotein E and sexShraddha Sapkota, Joel Ramirez, Vanessa Yhap, et al.
International Journal of Geriatric Psychiatry|September 8, 2015
Apolipoprotein E and Clusterin can magnify effects of personality vulnerability on declarative memory performance in non-demented older adultsShraddha Sapkota, Sandra A Wiebe, Brent J Small, et al.
Alzheimer'S Research & Therapy|September 7, 2018
Clinical dementia severity associated with ventricular size is differentially moderated by cognitive reserve in men and womenShraddha Sapkota, Joel Ramirez, Donald T Stuss, et al.
Pageof 2